In This Section
Recent Events

View all events

Cefuroxime

Cefuroxime sodium for injection is indicated for the treatment of infections caused by susceptible strains of the designated micro-organisms, or before the infecting organism has been identified, in the diseases listed below.

Respiratory tract infections, for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and postoperative chest infections.

Ear, nose and throat infections, for example, sinusitis, tonsillitis and pharyngitis. Urinary tract infections, for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria.

Soft tissue infections, for example, cellulitis, erysipelas, peritonitis and wound infections. Bone and joint infections, for example, osteomyelitis and septic arthritis. Obstetric and gynaecological infections, pelvic inflammatory disease. Gonorrhoea, particularly if penicillin is unsuitable.

Other infections, including septicaemia and meningitis. Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection.

Consideration should be given to official local guidance (eg, national recommendations) on the appropriate use of antibacterial agents.

Summary of Product's Characteristics (SPC)

Please click here for the UK SPC details

Cefuroxime
Product type:

Antibiotic


Availability:

Prescription Only (POM)


Available as:
Injection:

750mg, 1.5g

Call us on
+44 (0)1438 727 822
Email Us
medinfo@flynnpharma.com
Enquire Online
Thank you for letting us use cookies to improve your experience. For more information on the cookies we use see our privacy policy.